TrialPloS one2011

Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone.

Mi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.